NCT00497159View on ClinicalTrials.gov

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Huntington's Disease
Interventions
OTHER

Placebo

Placebo TID x 90 days

DRUG

Dimebon

Dimebon 20 mg TID x 90 days

Trial Locations (1)

14620

Huntington Study Group, Rochester

Sponsors

Lead Sponsor

Medivation, Inc.
All Listed Sponsors
collaborator

Huntington Study Group

NETWORK

lead

Medivation, Inc.

INDUSTRY

NCT00497159 - A Study of the Novel Drug Dimebon in Patients With Huntington's Disease | Biotech Hunter | Biotech Hunter